6:30 to 9:00 p.m.
Denver Sheraton Hotel: Grand Ballroom
The PAH Dinner Dialogue
PAH Dinner Dialogue is an educational presentation in an interactive environment where attendees and key opinion leaders analyze PAH case studies. Case studies are:
| • | Treating PAH in a Mildly Symptomatic Patient |
| • | What Is the Place for Inhaled Therapy in a FC III Patient? |
| • | I.V. Therapy Options in the Current Era |
Speakers: Richard N. Channick, MD, Chair, Massachusetts General Hospital, Boston, MA; Vallerie V. McLaughlin, MD, University of Michigan Health System, Ann Arbor, MI; and Sean M. Studer, MD, Newark Beth Israel Medical Center, Newark, NJ
Organizer: Actelion Pharmaceuticals US, Inc.
6:30 to 9:30 p.m.
Grand Hyatt Denver: Grand Ballroom
Overview of Cayston and Patient Profile Discussion
This symposium will discuss Pseudomonas aeruginosa infection and Cystic Fibrosis, and the efficacy and safety of Cayston (aztreonam for inhalation solution) as the first FDA-approved inhaled antibiotic in over a decade for patients with cystic fibrosis and Pseudomonas aeruginosa. As part of the symposium, patient profiles based on actual cases will be reviewed.
Speakers: Anas Hadeh, MD, FCCP, Associate Staff, Department of Pulmonary, Critical Care and Sleep Medicine, Cleveland Clinic Florida; Assistant Professor of Medicine (Adjunct), Drexel University College of Medicine, Philadelphia, PA
Organizer: Gilead Sciences, Inc.